Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$15.07 - $24.05 $6,404 - $10,221
425 Added 13.85%
3,493 $71,000
Q2 2023

Aug 10, 2023

BUY
$16.59 - $23.6 $2,787 - $3,964
168 Added 5.79%
3,068 $60,000
Q1 2023

May 15, 2023

SELL
$15.79 - $22.6 $4,815 - $6,893
-305 Reduced 9.52%
2,900 $49,000
Q4 2022

Jun 14, 2023

BUY
$15.5 - $22.76 $4,727 - $6,941
305 Added 10.52%
3,205 $62.7 Million
Q4 2022

Mar 30, 2023

BUY
$15.5 - $22.76 $9,625 - $14,133
621 Added 24.03%
3,205 $62,000
Q4 2022

Feb 15, 2023

BUY
$15.5 - $22.76 $9,625 - $14,133
621 Added 24.03%
3,205 $62,000
Q3 2022

Jun 14, 2023

SELL
$12.37 - $18.41 $3,908 - $5,817
-316 Reduced 10.9%
2,584 $41.2 Million
Q2 2022

Jun 20, 2023

SELL
$7.96 - $16.64 $2,515 - $5,258
-316 Reduced 10.9%
2,584 $35,000
Q1 2022

Jun 20, 2023

SELL
$13.16 - $23.68 $4,158 - $7,482
-316 Reduced 10.9%
2,584 $40,000
Q1 2022

Mar 30, 2023

SELL
$13.16 - $23.68 $109,241 - $196,567
-8,301 Reduced 76.26%
2,584 $40,000
Q1 2022

May 12, 2022

SELL
$13.16 - $23.68 $109,241 - $196,567
-8,301 Reduced 76.26%
2,584 $41,000
Q4 2021

Jun 21, 2023

BUY
$21.52 - $36.02 $171,837 - $287,619
7,985 Added 275.34%
10,885 $237,000
Q3 2021

Jun 21, 2023

BUY
$27.42 - $48.97 $218,948 - $391,025
7,985 Added 275.34%
10,885 $325,000
Q2 2021

Jun 21, 2023

BUY
$39.41 - $47.25 $314,688 - $377,291
7,985 Added 275.34%
10,885 $482,000
Q2 2021

Mar 30, 2023

BUY
$39.41 - $47.25 $25,734 - $30,854
653 Added 6.38%
10,885 $482,000
Q2 2021

Aug 16, 2021

BUY
$39.41 - $47.25 $428,583 - $513,843
10,875 Added 108750.0%
10,885 $482,000
Q1 2021

Jun 26, 2023

BUY
$43.34 - $65.91 $317,768 - $483,252
7,332 Added 252.83%
10,232 $454 Million
Q1 2021

Mar 30, 2023

SELL
$43.34 - $65.91 $16,642 - $25,309
-384 Reduced 3.62%
10,232 $453,000
Q1 2021

May 14, 2021

SELL
$43.34 - $65.91 $459,664 - $699,041
-10,606 Reduced 99.91%
10 $454,000
Q4 2020

Jun 22, 2023

BUY
$23.3 - $59.57 $179,782 - $459,642
7,716 Added 266.07%
10,616 $582,000
Q3 2020

Jun 26, 2023

BUY
$20.5 - $28.59 $158,178 - $220,600
7,716 Added 266.07%
10,616 $242,000
Q2 2020

Jun 26, 2023

BUY
$13.32 - $22.61 $102,777 - $174,458
7,716 Added 266.07%
10,616 $222,000
Q1 2020

Jul 12, 2023

BUY
$9.71 - $25.11 $74,922 - $193,748
7,716 Added 266.07%
10,616 $148,000
Q4 2019

Jul 12, 2023

BUY
$11.07 - $24.23 $85,416 - $186,958
7,716 Added 266.07%
10,616 $241,000
Q3 2019

Jul 12, 2023

BUY
$10.85 - $14.78 $83,718 - $114,042
7,716 Added 266.07%
10,616 $123,000
Q3 2019

Mar 30, 2023

BUY
$10.85 - $14.78 $34,861 - $47,488
3,213 Added 43.4%
10,616 $123,000
Q3 2019

Nov 14, 2019

BUY
$10.85 - $14.78 $34,861 - $47,488
3,213 Added 43.4%
10,616 $124,000
Q2 2019

Jul 12, 2023

BUY
$15.0 - $19.81 $77,955 - $102,952
5,197 Added 179.21%
8,097 $121,000
Q1 2019

Jul 13, 2023

BUY
$13.45 - $19.01 $60,565 - $85,602
4,503 Added 155.28%
7,403 $129,000
Q1 2019

Mar 30, 2023

BUY
$13.45 - $19.01 $56,463 - $79,803
4,198 Added 130.98%
7,403 $129,000
Q1 2019

May 16, 2019

BUY
$13.45 - $19.01 $44,721 - $63,208
3,325 Added 81.54%
7,403 $129,000
Q1 2019

May 15, 2019

SELL
$13.45 - $19.01 $44,721 - $63,208
-3,325 Reduced 44.91%
4,078 $428,000
Q4 2018

Jul 13, 2023

BUY
$11.21 - $23.53 $50,478 - $105,955
4,503 Added 155.28%
7,403 $109,000
Q4 2018

Feb 14, 2019

BUY
$11.21 - $23.53 $64,816 - $136,050
5,782 Added 356.69%
7,403 $110,000
Q3 2018

Jul 13, 2023

BUY
$18.5 - $25.49 $83,305 - $114,781
4,503 Added 155.28%
7,403 $182 Million
Q3 2018

Nov 14, 2018

BUY
$18.5 - $25.49 $29,988 - $41,319
1,621 New
1,621 $40,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $851M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.